CIBC Private Wealth Group’s Aldeyra Therapeutics ALDX Stock Holding History

CIBC Private Wealth Group’s Portfolio ALDX Stock Details ALDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$54.4K	Hold	10,505	–	–	﹤0.01%	1746
2025 Q3	$54.8K	Buy	+10,505	New	+$54.8K	﹤0.01%	1748
2025 Q2	–	Sell	-40,953	Closed	-$78.6K	–	3081
2025 Q1	$78.6K	Sell	40,953 -10,505	-20%	-$62.1K	﹤0.01%	1445
2024 Q4	$263K	Hold	51,458	–	–	﹤0.01%	1060
2024 Q3	$277K	Hold	51,458	–	–	﹤0.01%	1049
2024 Q2	$170K	Buy	+51,458	New	+$202K	﹤0.01%	1181
2023 Q4	–	Sell	-17,150	Closed	-$115K	–	1145
2023 Q3	$115K	Buy	+17,150	New	+$127K	﹤0.01%	1031

Other funds holding ALDX

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

CIBC Private Wealth Group's ALDX Position: Q4 2025 in Review

CIBC Private Wealth Group held its Aldeyra Therapeutics (ALDX) position steady in Q4 2025 at 10,505 shares worth $54.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1746.

CIBC Private Wealth Group first reported a position in ALDX in Q3 2023 and has held it in 7 quarters since. The position peaked at $277K in Q3 2024. 135 funds tracked by Wall St. Rank hold ALDX as of Q4 2025.

CIBC Private Wealth Group held 10,505 shares of Aldeyra Therapeutics worth $54.4K as of Q4 2025.
CIBC Private Wealth Group left its Aldeyra Therapeutics share count unchanged in Q4 2025.
Aldeyra Therapeutics made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1746 holding.
CIBC Private Wealth Group first reported a position in Aldeyra Therapeutics in Q3 2023 and has held it in 7 quarters since.
CIBC Private Wealth Group's Aldeyra Therapeutics position peaked at $277K in Q3 2024.
135 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.